Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.
about
Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Neoadjuvant everolimus plus le ...... for a randomized pilot trial.
@en
Neoadjuvant everolimus plus le ...... for a randomized pilot trial.
@nl
type
label
Neoadjuvant everolimus plus le ...... for a randomized pilot trial.
@en
Neoadjuvant everolimus plus le ...... for a randomized pilot trial.
@nl
prefLabel
Neoadjuvant everolimus plus le ...... for a randomized pilot trial.
@en
Neoadjuvant everolimus plus le ...... for a randomized pilot trial.
@nl
P2093
P2860
P1433
P1476
Neoadjuvant everolimus plus le ...... for a randomized pilot trial.
@en
P2093
Heran Deng
Jieqiong Liu
Minghui Cao
Nanyan Rao
Yaping Yang
P2860
P2888
P356
10.1186/S13063-017-2228-5
P577
2017-10-25T00:00:00Z
P6179
1092353867